about
Trypanothione-dependent glyoxalase I in Trypanosoma cruziThe identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase IZopolrestat as a human glyoxalase I inhibitor and its structural basisCharacterization of the glyoxalases of the malarial parasite Plasmodium falciparum and comparison with their human counterpartsAdipose tissue dysfunction and its effects on tumor metabolismDifferential response to α-oxoaldehydes in tamoxifen resistant MCF-7 breast cancer cells.Structural studies on a mitochondrial glyoxalase II.Pathological significance of mitochondrial glycationMolecular enzymology of the glyoxalase system.Methylglyoxal, diabetes mellitus and diabetic complications.Comparative proteomics analysis of oral cancer cell lines: identification of cancer associated proteins.Methylglyoxal metabolism in trypanosomes and leishmania.Distinct classes of glyoxalase I: metal specificity of the Yersinia pestis, Pseudomonas aeruginosa and Neisseria meningitidis enzymes.The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety, dementia and Parkinson's diseaseStructural basis for 18-β-glycyrrhetinic acid as a novel non-GSH analog glyoxalase I inhibitor.Plasmodium falciparum glyoxalase II: Theorell-Chance product inhibition patterns, rate-limiting substrate binding via Arg(257)/Lys(260), and unmasking of acid-base catalysis.Gene expression in mouse brain following chronic hypoxia: role of sarcospan in glial cell death.Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions.Identification of curcumin derivatives as human LMTK3 inhibitors for breast cancer: a docking, dynamics, and MM/PBSA approach.
P2860
Q24682276-E0A1E81F-7442-440E-91C5-00CC9D8C2850Q27651522-A2AD334D-733E-4DBD-996B-064EC92C7C20Q27685231-EA34863A-A68E-4764-8931-CD6ECBFE745CQ27973443-58AB1391-9A9F-45BF-B3B0-672C873CD18AQ28080748-C381822A-AF7D-4F12-8D3A-FA71F0063F3EQ33831129-2A850434-D11C-4656-96EE-6B27E7C90749Q34293884-CA59F17F-1EFC-49ED-B259-D63816630362Q36072507-34D5CF94-22C2-4F6A-8325-9A4387D23434Q37183276-53D33341-47DA-4C47-B75C-ED05C6C529D6Q37183293-7E058965-C50F-47C2-8E36-53030074DD31Q37681877-DFD9932C-4218-4F34-B93D-1C4FA332FF9AQ37839329-2BE9CD98-E110-4804-BB0E-3783E4A4BDFFQ41461864-A3FA7861-5C33-452A-AF4F-2E36C20A17ACQ41852765-2C983068-4E3C-4454-B6AD-5862485A487DQ42005470-798343DE-FB85-4503-8119-ECCC28C70321Q43296434-D00DFFEE-3697-47EA-A879-D7B38007A1F8Q46192392-F5B024B4-981A-4B9E-A9AE-2524A96CF9F1Q46966682-DEE04455-9A56-45FD-B633-C151ACD8A31AQ54979886-568CD42E-3DE1-4FAF-BC7B-DD4B97090091
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glyoxalase I inhibitors in cancer chemotherapy.
@ast
Glyoxalase I inhibitors in cancer chemotherapy.
@en
type
label
Glyoxalase I inhibitors in cancer chemotherapy.
@ast
Glyoxalase I inhibitors in cancer chemotherapy.
@en
prefLabel
Glyoxalase I inhibitors in cancer chemotherapy.
@ast
Glyoxalase I inhibitors in cancer chemotherapy.
@en
P2093
P356
P1476
Glyoxalase I inhibitors in cancer chemotherapy.
@en
P2093
Creighton DJ
Eiseman JL
Hamilton DS
Holewinski R
P304
P356
10.1042/BST0311378
P577
2003-12-01T00:00:00Z